Imuneks Farma was established by the owners of MN Pharma, who have been in the
pharma&healthcare business since 1923 They launched Eli. Lilly’s operations in
Turkey 50 years ago in Turkey and were in charge of the manufacturing and sales of
their portfolio for decades, MN also had partnerships with companies such as nippon
kayaku, Kyowa hakko and Celltrion, wherein we manufactured, launched and marketed their products in the Turkish market.
After the acquisition of MN Pharmaceuticals by Amgen, Imuneks Farma has bought
back the otc business of MN Pharma which now includes one of the highest selling
medical OTC lines in Turkey. The company has grown more than 700% over a 7 year
period with the addition of new product lines and with the help of a sales team of 35 reps.
The owners of İmuneks Farma still own one of the oldest industrial holding
companies in Turkey as well. http://www.pakgroup.com/en/aboutus.html Apart from 3 super generics developed for pain management, one of which was licensed and then sold to a big pharma company. IMF is also the only company in Turkey developing original RX pharmaceutical treatments with studies in oncology, pain management, virology and auto immune diseases with more than 40 patent applications and several different patents granted in the E.U.
U.S.A and Japan. Furthermore, IMF has completed it’s phase 2b in
ano-genital warts with best in class results.(90% complete clearance rate in AVG 3 weeks.) as a best in class therapeutic and also an original treatment in phase III for Covid-19.
Orijinal Ürün ve ARGE EN
Etkin Madde Konsantrasyonu
Bilimsel Kanıtlara Dayalı
Kaliteli Ürün, Güvenli Kullanım
1923’e Dayalı Köklü Geçmiş
1923’te başladığımız yolculuğumuza;
İnovasyon ve kalite odaklı, yenilikçi anlayışımızla devam ediyoruz…